AstraZeneca has reported a record quarter for revenue including $1.8bn from its Covid-19 vaccine and sales from its $39bn acquisition of rare disease company Alexion.
阿斯利康(AstraZeneca)公布了创纪录的季度营收，其中包括来自新冠疫苗的18亿美元收入，以及其以390亿美元收购的罕见疾病公司Alexion的销售额。
您已阅读12%（245字），剩余88%（1884字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。